News

Home > News > News

2017/03/09

CCSB obtained TW patent for Edoxaban Intermediate

The Taiwanese Patent Office has granted Chunghwa Chemical Synthesis & Biotech Co. Ltd. (CCSB) a process patent on the API manufacturing of Edoxaban on February 21, 2017. The patent “PROCESS FOR PRODUCING DIAMINE DERIVATIVE” (I 571460) is based on proprietary technology developed by CCSB, including novel manufacture method and solutions to previous issues such as reaction system solidification and process control monitoring. In addition, the patent technology improves API product stability, production yield, and personnel and environmental safety.